Gene · 56896
DPYSL5: dihydropyrimidinase like 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DPYSL5: dihydropyrimidinase like 5. Genes, record 56896. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/56896
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BPU6 | Dihydropyrimidinase-related protein 5 | 564 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 43799 | Q9BPU6 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43800 | Q9BPU6 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2946 | Q9BPU6 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2946 | Q9BPU6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 24408 | Q9BPU6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 24409 | Q9BPU6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 24413 | Q9BPU6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 127379 | Q9BPU6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 127380 | Q9BPU6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 127384 | Q9BPU6 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants415
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DPYSL5 papers | Newest fiscal year |
|---|---|---|---|
| R01NS126227 | Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
| R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 3 | 2025 |
| K12EY021475 | UIC K12 independent Clinical Vision Scientist Development Program | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 2 | 2025 |
| R35NS116843 | Continuous Neurogenesis in the Mammalian Hippocampus | 2 | 2025 |
| R35NS137480 | Epitranscriptomic regulation in the mammalian nervous system | 2 | 2025 |
| T32CA009531 | Training Program in the Biology of Cancer | 2 | 2025 |
1 to 10 of 415Source NIH's project files
See all 415 nih grantsPapers1,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myasthenia gravis with thymoma-associated CRMP5/CV2 antibody-positive paraneoplastic neurological syndrome: a case report and literature review. | Front Immunol | 2026 | 42807089 | PubTator, text mining | PubMed |
| Spatially Contextualized Integrative Genomics Highlights Neuronal and Glial Regulatory Programs in Low Back Pain. | J Pain Res | 2026 | 42699694 | PubTator, text mining | PubMed |
| Correlation between Antiretinal Antibodies and OCT Manifestations in Nonparaneoplastic Autoimmune Retinopathy. | Ophthalmol Sci | 2026 | 42437120 | PubTator, text mining | PubMed |
| Glucocorticoid Signaling in PSC-Derived Neural Systems to Elucidate Mechanisms of Stress-Induced Psychiatric Vulnerability. | Mol Neurobiol | 2026 | 42412256 | PubTator, text mining | PubMed |
| Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review. | J Neuroimmunol | 2026 | 42372569 | PubTator, text mining | PubMed |
| Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders. | Cells | 2026 | 41892327 | PubTator, text mining | PubMed |
| Mixed Signals and Interspecies Variation in the Plasticity of Adult Mammal Brains. | Cells | 2026 | 41892311 | PubTator, text mining | PubMed |
| Integrative genomic and spatial transcriptomic analysis elucidates the oligodendrocyte-mediated etiology of epileptic cortical thinning. | Epilepsia Open | 2026 | 41885647 | PubTator, text mining | PubMed |
| Paraneoplastic neuromyelitis optica spectrum disorder with dual AQP4-IgG and CRMP5 antibodies following thymectomy: a case report. | Front Neurosci | 2026 | 41878006 | PubTator, text mining | PubMed |
| Morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis. | BMJ Case Rep | 2026 | 41856686 | PubTator, text mining | PubMed |
1 to 10 of 1,315
See all 1,315 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/56896
GET https://conductscience.org/api/genes/v1/56896/patents?page=2